Business Context and Reporting Period
Company: Prestige Brands Holdings, Inc. (Note: Filing lists registrant as Prestige Brands Holdings, Inc., though request metadata references Prestige Consumer Healthcare Inc.)
Filing Type: Form 8-K (Current Report)
Date: December 20, 2011
Event: Announcement of definitive agreements to acquire 17 over-the-counter (OTC) pharmaceutical brands from GlaxoSmithKline plc and affiliates.
Key Financial Metrics
Transaction Value: $660 million in cash.
Assets Acquired: 17 OTC pharmaceutical brands sold in North America.
Financial Performance: The filing text does not provide specific revenue, profit, cash flow, margin, debt, or liquidity figures for the reporting period. This document focuses solely on the acquisition announcement.
Material Changes
Strategic Expansion: The Company has entered into definitive agreements to significantly expand its product portfolio through the acquisition of 17 new brands.
Capital Deployment: The transaction requires a cash outlay of $660 million, contingent upon the closing of committed financing.
Outlook, Risks, and Contingencies
- Closing Timeline: Transactions are expected to complete in the first half of calendar year 2012.
- Conditions Precedent: Closing is subject to customary legal and regulatory conditions, including clearance under the Hart-Scott Rodino Antitrust Improvements Act of 1976.
- Financing: Completion is contingent upon the Company closing on its committed financing for the acquisitions.
- Management Commentary: The Company began investor presentations on December 20, 2011, utilizing an attached Investor Presentation (Exhibit 99.2).
Investor Verification Checklist
- Verify the status of the Hart-Scott Rodino Antitrust clearance.
- Confirm the closing of the committed financing required for the $660 million cash payment.
- Review the attached Press Release (Exhibit 99.1) and Investor Presentation (Exhibit 99.2) for detailed brand lists and strategic rationale.
- Monitor subsequent filings for updates on the transaction closing date, as the filing states no obligation to update information unless warranted by management.